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Abstract
Background: Bovine herpesvirus 4 (BoHV-4) is a gammaherpesvirus whose genome was cloned as Bacterial
Artificial Chromosome (BAC) and exploited as a gene delivery vector for vaccine purposes. Although BoHV-4
genome has been completely sequenced and its open reading frames (ORFs) structurally defined in silico, most of
them are not functionally characterized. In BoHV-4 genome two major immediate early genes (IE) are present, IE1
and IE2. IE2 is an essential gene because its removal from the viral genome renders the virus unable to replicate,
whereas for IE1 no many functional information are available.
Results: In this work, IE1 contribution in initiating and maintaining BoHV-4 lytic replication was assessed generating
a recombinant BoHV-4 genome lacking of IE1 gene, BoHV-4ΔIE1. In contrast to BoHV-4IE2 deleted mutant, BoHV-4ΔIE1
infectious replicating viral particles (IRVPs) could be reconstituted following viral DNA electroporation in permissive
cells. However the titer of BoHV-4ΔIE1 IRVPs produced into the cell supernatant and BoHV-4ΔIE1 plaques size were
reduced respect to BoHV-4 undeleted control. Further the impaired BoHV-4ΔIE1 IRVPs produced into the cell
supernatant could be rescued by expressing IE1 gene product in trans, confirming the implication of IE1 in BoHV-4
lytic replication. Next, the possible role of BoHV-4IE1 as bone marrow stromal cell antigen 2 (BST-2) counteracting
factor, as hypothesized by IE1 amino-terminal gene product homology with Kaposi Sarcoma Associated
Herpesvirus (KSHV) K5, was excluded too.
Conclusions: Although the real function of BoHV-4IE1 is still elusive, a new BoHV-4 genome gene locus as a target site
for the insertion of foreign DNA and resulting in the attenuation of the virus has been revealed. These data can be
considered of relevance to improve BoHV-4 gene delivery properties.
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Background
Bovine herpesvirus 4 (BoHV-4) is a gammaherpesvirus
of the genus Rhadinovirus, and has been isolated both in
healthy animals and in animals with variable diseases,
from ocular discharge, conjunctivitis, dermatitis, respira-
tory diseases and abortion [1–3]. The pathogenic role of
BoHV-4 remains unclear, even if there is increasing evi-
dence of a secondary pathogenic role in bovine post-
partum metritis [3–8]. The coding capacity of BoHV-4
has been described as well as the common and unique
features of the BoHV-4 genome in comparison to those
of other gammaherpesviruses. However many of BoHV-4
genes and their products have not been functionally char-
acterized [9].
BoHV-4 gene expression cascade is similar to that of
other herpesviruses and comprises Immediate Early (IE),
Early (E) and Late (L) gene expression [10]. Herpesvirus
IE genes are experimentally defined as those which are
transcribed when cells are infected in the presence of
protein synthesis inhibitor, because IE gene expression
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does not require de novo viral protein synthesis. Under
this conditions, RNA transcribed from IE genes usually
accumulates to higher levels than in absence of inhibi-
tors, presumably because of the lack of feed-back inhib-
ition. Two major BoHV-4IE RNAs were characterized
early during infection in the presence of cycloheximide,
IE1 and IE2 [11]. Although both of them have been well
characterized in terms of gene structure, transcription
and RNA post-transcriptional processing [11, 12], the
only one to be functionally characterized was IE2 [13, 14].
The generation of viral mutants targeting the IE2 locus
within the BoHV-4 genome, provided the direct demon-
stration that BoHV-4 gene product, ORF50/Rta, is indis-
pensable in initiating and allowing progression of BoHV-4
lytic replication [13, 14]. In fact a recombinant BoHV-4 in
which ORF50/Rta was deleted was completely unable to
replicate, but was efficiently rescued, with respect to
production of infectious virus and DNA replication, upon
the expression of ORF50/Rta in trans [14]. Whereas as
regards BoHV-4IE1 gene, it is the most abundant viral
RNA transcribed in the presence of cycloheximide, though
its abundance is greatly reduced in absence of inhibitor,
suggesting a down regulation by newly synthesized viral
proteins [11]. Since BoHV-4IE1 RNA is the major RNA
found under IE conditions, it was referred to it as the
major IE RNA [11]. IE1 is a spliced, 1,7 kb RNA, contain-
ing four exons and transcribed from the right to the left of
BoHV-4 genome. IE1 open reading frame (ORF) codes for
a protein of 285 amino acids (aa) with a predicted molecu-
lar weight of 33 kDa and an unknown function [11].
Therefore, the purpose of the present work was to knock-
down BoHV-4IE1 gene in BoHV-4 genome cloned as a
BAC, to reveal its potential contribution in initiating and
maintaining BoHV-4 lytic replication.
Results and discussion
Generation of a BoHV-4IE1 deleted mutant
Although BoHV-4IE1 is simultaneously expressed along
with IE2 during BoHV-4 life cycle and IE2 has a pivotal
role in initiating the BoHV-4 transcriptional replication
[13, 14], it was of interest to know if IE1 could have an
essential role similarly to that observed for IE2. The
main way to achieve this kind of information was to
knock-down IE1 gene coding regions by heat inducible
homologous recombination into the genome of BoHV-4
cloned as bacterial artificial chromosome. A targeting
fragment, IE1L-KanaGalK-IE1R, containing the 2232
base-pairs (bp) KanaGalK double selecting cassette [15]
flanked by two BoHV-4IE1 gene homologous sequences,
was introduced between the BoHV-4 genome position
19,672 and 20,229. This insertion, comprising the full
deletion of the IE1 third exon and most of the fourth
exon, resulted with the elimination of the 70 % of the
IE1 coding regions. Many genes of BoHV-4 genome are
overlapped and the coding region of a gene can also
works as a regulatory region for the neighboring gene.
This IE1 gene knock-down strategy allowed maintaining
intact the Bo4 and Bo6 gene promoter, thus preserving
their transcription and translation (data not shown).
Therefore, the viral phenotype obtained from this inser-
tion/deletion was exclusively due to BoHV-4IE1 knock-
down and not contaminated by the loss of expression of
the flanking genes, in this specific case Bo4 and Bo6
(Fig. 1a). To generate BoHV-4 with knocked-down IE1
gene, BoHV-4ΔIE1, linearized pIE1L-KanaGalK-IE1R
was electroporated in SW102 E. coli containing pBAC-
BoHV-4 genome and pBAC-BoHV-4ΔIE1 was gener-
ated. The authenticity of the selected targeted clones
were checked by PstI restriction enzyme digestion and
confirmed by southern hybridization by a specific probe
(Fig. 1b). Further, pBAC-BoHV-4ΔIE1 clone stability in
SW 102 E. coli, before to attempt the reconstitution of
the IE1 deleted virus, was assessed by serial passages
(over 20) and PstI digestion. pBAC-BoHV-4ΔIE1 was
stable as observed by the absence of differences among
the restriction profile of pBAC-BoHV-4ΔIE1 derived from
different passages (Fig. 1c).
BoHV-4ΔIE1 has an impaired replication
Herpesvirus gene expression cascade and replication is
mainly governed by the immediate early gene expres-
sion. The competence of the viral DNA genome to re-
constitute Infectious Replicating Viral Particles, IRVPs,
can be tested by transfecting the mutant viral genome in
permissive cell lines and this is greatly facilitated if the
viral genome, as is the case of BoHV-4, is cloned as a
BAC. As a first approach to test the characteristics of
the viral phenotype obtained from IE1 knock-down, a
viral reconstitution assay was employed. BEK cells and
BEKcre cells, constitutively expressing cre recombinase
[16] to excise out the floxed BAC cassette from the viral
genome, were electroporated with pBAC-BoHV-4, pBAC-
BoHV-4ΔIE1 and pBAC-BoHV-4ΔTK, a mutant BoHV-4
genome in which the 2232 bp KanaGalK double selectable
marker was inserted into the BoHV-4 thymidine kinase
(TK) gene [17–19] without interfering with the replication
property of the resulting virus. Surprisingly, all three ge-
nomes could efficiently reconstitute IRVPs (Fig. 2a) and
this was the first consisting indication that IE1 is not an
essential gene contrarily to what it was observed for
BoHV-4IE2 and gB Knock-down, which gave a complete
replicating uncompetent phenotype [14, 18]. Although the
viral reconstitution assay is very informative from the
qualitative point of view, on the other hand it is poorly
quantitative. Thus the replication kinetics of BoHV-4ΔIE1
and BoHV-4 obtained from pBAC-BoHV-4ΔIE1 and
pBAC-BoHV-4 BEKcre transfected cells were compared.
A slower replication, of ~1 log, for BoHV-4ΔIE1 respect
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to BoHV-4 was observed (Fig. 2b). Although IE genes are
the first genes to be transcribed during the infection, their
function can be protracted for the entire viral replication
cycle. BoHV-4 is a Gammaherpesvirus with a slow replica-
tion cycle respect to alpha and beta herpesvirus and this is
the reason why we see differences during the late infec-
tion. This data was corroborated by the reduction of the
plaque size generated by BoHV-4ΔIE1 respect to BoHV-4
(Fig. 2c and d).
BoHV-4-ΔIE1 impaired replication can be rescued by IE1
expressed in trans
To confirm that the impaired replication, despite of
small entity (~1 log) but significant, observed for BoHV-
4ΔIE1, was due to the loss of IE1 and not a mere
artifact, BEK cells constitutively expressing IE1 were
generated to rescue in trans the loss of IE1. IE1 ORF
cDNA was obtained by PCR with an antisense primer
containing a restriction site, a kozak’s sequence and
Fig. 1 Generation of BoHV-4-ΔIE1. a Schematic representation (not on scale) of the overall strategy to knock-down IE1 gene in BoHV-4 genome
clone in SW 102 E. coli. Bo4 (orange), Bo5 [(IE1), blue] and Bo6 (green) gene coding regions are indicated by numbers, which represent nucleotide
positions within the BoHV-4 genome [based on the BoHV-4-66p347 complete genome published sequence (GenBank accession number AF318573)].
The targeting fragment (red), IE1L-KanaGalK-IE1R, flanked by two homologous sequences allowed the insertion of the double selectable marker
KanaGalK between the positions 19,672 and 20,229, deleting most of the IE1 coding region but leaving intact the Bo4 and Bo6 promoters. IE1 locus
possess two PstI sites, one at the position 16,653 and one at the position 24,453, generating a fragment of 7800 bp. After targeting, a new PstI site,
delivered by the targeted vector, was introduced into the IE1 locus and thus generating three PstI restriction sites and two PstI digestion product, of
4224 and 5251 bp respectively. PstI restriction enzyme digestion allowed to distinguish between targeted and untargeted clones (b), in fact the
targeted clones (pBAC-BoHV-4ΔIE1) display two new bands (indicated by red arrows) respect to the untargeted control clone (pBAC-BoHV-4; indicated
by the yellow arrow). This is further confirmed by southern blotting with a specific probe for KanaGalK (red circle). c Clonal stability of pBAC-BoHV-4ΔIE1
in SW 102 E. coli at passage 1, 5, 10, 15, 20 and analyzed by PstI restriction digestion
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matching the first eight codons comprising the atg,
and a sense primer matching the last eight codons, in-
cluding the stop codon, end ending with a restriction site
(Table 1; Fig. 3a). So generated IE1 ORF cDNA was sub
cloned in a bicistronic expression vector provided of the
CMV promoter, an internal ribosomal entry site (IRES)
and a selectable marker (neo) (Fig. 3a). pCMV-IE1-IRES-
neo was electroporated in BEK cells and cells selected with
G418 to get BEK/IE1 cells. Next, BoHV-4ΔIE1 and
BoHV-4 replication kinetics were compared on BEK/IE1
cells. As hoped, and showed in Fig. 3b, the gap of replica-
tion between BoHV-4ΔIE1 and BoHV-4 was filled by ex-
pressing IE1 in trans. Although a revertant strain could be
generated, however it was reasoned that a revertant strain
is not so much different from a wild type and for this
reason it was preferred the expression in trans of the mu-
tated gene.
BoHV-4IE1 is not a tethering counteracting factor
Despite BoHV-4IE1 gene deletion gave a mild phenotype
that could be rescued by BoHV-4IE1 gene expression in
trans, the real function of BoHV-4IE1 gene, in the con-
test of viral replication, remained elusive. However from
in silico study it was noticed that BoHV-4IE1 shares a
conserved amino-terminal domain with the K5/K3-fam-
ily gamma-2 herpesvirus plant homeo domain (PHD)/
leukemia associated protein (LAP)-finger type [20]. In a
proteomics screen for new host targets of KSHV K5, it
was observed that bone marrow stromal cell antigen 2
(BST-2, also called tetherin), an interferon-induced protein
Fig. 2 Characterization of BoHV-4-ΔIE1. a Representative images (phase contrast, fluorescence and merged; 10×) of BEK and BEK expressing cre
(BEKcre; in the right panel) electroporated with pBAC-BoHV-4 and pBAC-BoHV-4ΔIE1 DNA. CPE induced by reconstitution of IRVPs is recognizable
for all three BAC viral genomes (dark pictures in fluorescence for BAC transfected BEKcre cells is due the loss of GFP expression cassette contained
in the floxed BAC backbone removed by cre recombinase). The test was repeated three times always giving identical results. b Replication kinetics
of BoHV-4ΔIE1 (red line) and BoHV-4 (blue line). c Representative images (4× and 10×) showing plaque morphology and relative plaque sizes of
BoHV-4 and BoHV-4ΔIE1 on Vero cells. d The plaque sizes (μm2) were measured using the Axio-Vision40-V4.6.3.0 (Carl Zeiss, Imaging Solution)
software program. Bars represent means ± standard errors of 50 plaques for each virus [(**) P≤ 0.001)]. Significance was measured by ANOVA
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with the unique ability to restrict the egress of some en-
veloped viruses [21], was counteracted in terms of viral
egress restriction activity in the presence of K5 [22]. More
recently, it was demonstrated that, similar to other K5 tar-
gets, BST-2 is ubiquitinated by K5, resulting in ubiquitin-
mediated endocytosis and lysosomal destruction [23].
Starting from these information the potential BoHV-4IE1
counteracting properties toward BST-2 were investigated.
For this purpose a cell line, BEK-boBST-2, over expressing
bovine BST-2 (boBST-2) was generated by stably trans-
fecting BEK cells with a bicistronic construct, pCMV-
boBST-2-IRES-neo, delivering a FLAG tagged boBST-2
ORF (Fig. 4a). G418 selected BEK-boBST-2 cells stably
overexpressed boBST-2, as shown by western immu-
noblotting with a monoclonal antibody directed against
the FLAG tag (Fig. 4b). The over-expression of boBST-2
in BEK cells and the deletion of IE1 in BoHV-4 genome
should amplify the BoHV-4ΔIE1 phenotype, in terms of
restriction release of BoHV-4ΔIE1 IRVPs into the infected
BEK-boBST-2 cells supernatant, if BoHV-4IE1 was a real
BST-2 counteracting factor. Therefore, the replication
kinetics of BoHV-4ΔIE1 and BoHV-4 were compared on
BEK-boBST-2, BEK/IE1 and BEK cells. However no sig-
nificant viral titer decrease at 72 hs post infection for
BoHV-4ΔIE1 infected BEK-boBST-2 cells supernatant
respect to that of BoHV-4 infected BEK-boBST-2 cells
supernatant (Fig. 4c) was detected. This 1 log viral titer
difference remained equal to that revealed for BoHV-
4ΔIE1 and BoHV-4 infected BEK cells supernatants
(Fig. 2b). Moreover, noteworthy a paradoxical significant
increase of the viral titer, at 48 hs post infection, for
BoHV-4ΔIE1 infected BEK-boBST-2 cells supernatant
respect to the supernatant of BoHV-4ΔIE1 infected BEK
Fig. 3 Rescue of BoHV-4-ΔIE1 impaired replication in trans. a Schematic diagram (not on scale) of BoHV-4IE1 gene containing exons (A, B, C and D)
and introns (dashed lines), along with its reverse transcribed cDNA, amplified by PCR with a couple of primers containing restriction sites and to allow
its subcloning into the bicistronic vector. b Replication kinetics of BoHV-4ΔIE1 (red line) and BoHV-4 (blue line) on BEK/IE1 cells
Table 1 List of primers used in that work
Primer name 5′-3′ Primer sequence
IE1-left-sense 5′-CCC GAA TTC CAA TTG ACA ACA TAT AAA GTC-3′
IE1-left-antisense 5′-CCC GGT ACC CGA TTT GTC TTC ATT GCT GGT-3′
IE1-right-sense 5′-GGG CTG CAG AGC CAA AGA TGG CAT ATT GGG-3′
IE1-right antisense 5′-CCC AAG CTT CAA TTT CTT CAT TCC AAA CAC-3′
IE1-NheI-sense 5′-CCC GCT AGC CCA CC ATG GCC AGT AAA GAC T-5′








5′- CCA ACC CGG GAC GCG TGA AAT TGT AAG CGT
TAA TAA T-3′
BST2sense-EcoRV 5′-CCC GAT ATC CCACC ATG GAT TAC AAG GAT
GAC-3′
BST2anti-NheI 5′- CCC GCT AGC TCA GGT CAG CAG AGC GTT GAG
GAC-3′
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cells (Fig. 4d) was observed. Although this last data was
not further investigated, it could be assumed a role differ-
ent than a BST-2 counteraction factor for BoHV-4IE1
gene product. On the other hand the similarities observed
in silico between K5 and BoHV-4IE1 were very mild and
limited to the amino-terminal portion of the proteins
(Additional file 1). This could justify the lack of functional
similarity in terms of BST-2 counteracting activity ob-
served for IE1 and represents a classical demonstration
that the in silico prediction should be always experimen-
tally verified before to draw any conclusion.
Conclusions
BoHV-4 has been suggested as a vector for gene delivery
[15, 16, 19, 24–27]. Several molecular and biological char-
acteristics for this virus include: absence of oncogenicity,
ability to accommodate large amounts of foreign genetic
material, ability to be maintained in an episomal state in
Fig. 4 BoHV-4IE1 is not a tethering counteracting factor. a Schematic diagram (not on scale) of the bicistronic construct pCMV-boBST-2-IRES-neo
containing the CMV promoter (violet), the flag tagged boBST-2 (green) ORF, an internal ribosomal entry site (IRES; grey), the neo ORF (orange) and
a polyadenilation signal (pA; grey). b Western immunoblotting of BEK cells stably transfected with pCMV-boBST-2-IRES-neo (BEK-boBST-2 ) and
selected with G418. The lanes were loaded with different amounts of total protein cell extract (5, 10 and 20 μg). Negative control was established
with empty vector transfected cells (Mock). c Replication kinetics of BoHV-4ΔIE1 (red line) and BoHV-4 (blue line) on BEK-boBST-2 cells. d Replication
kinetics of BoHV-4ΔIE1 made on BEK cells (blue line) and compared to that made on BEK-boBST-2 cells (red line)
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dividing cells and capability to infect several cellular types
derived from different animal species. Although the gen-
ome of BoHV-4 has been sequenced completely [9, 28]
the functional importance of most of the genes remains
unknown. Targeting genes and regions of gene expression
regulation and the phenotypic analysis of the BoHV-4
mutants represents a powerful tool to study the direct and
indirect interactions of genes and genomic elements in a
biological context. The classification of equivalent phe-
notypes carrying different types of mutations will provide
insight into functional networks and their constituting ele-
ments. Fewer than 75–80 ORFs have been characterized
in BoHV-4, based on amino acids homology and genome
location and most of the genes have no apparent hom-
ology to known viral or cellular genes. Essential genes are
of particular importance and the inactivation of at least
one of them is required to create replication-incompetent
herpesvirus vectors for vaccination or gene therapy, while
non-essential genes can be removed to gain space for
insertion of therapeutic genes or generate attenuated vac-
cines, as it the case of IE1 investigated in the present
work. Therefore, these data are extremely valuable when




Bovine embryo kidney [(BS CL-94) BEK, from M. Ferrari,
Istituto Zooprofilattico Sperimentale, Brescia, Italy],
Madin Darby Bovine Kidney (MDBK, ATCC: CCL-22),
African green monkey kidney epithelial cells [(VERO,
ATCC: CCL-81) kindly provided by Professor S. Trees,
University of Liverpool], BEK expressing cre recombinase
(BEKcre) cells [16] and HEK [Human Embryo Kidney
293 T cells [(HEK 293 T) ATCC: CRL-11,268] were
cultured in EMEM (Lonza) containing 10 % FBS, 2 mM L-
glutamine (SIGMA), 100 IU/mL penicillin (SIGMA) and
100 mg/mL streptomycin (SIGMA) and 2.5 mg/mL
amphotericin B.
Plasmids generation and PCR reactions
pFlagbovTeth [29] was linearized with PvuI restriction
enzyme digestion and used as a template to amplify
flagged bovine tetherin ORF. The amplification was car-
ried over 35 cycles, each cycle consisting of denaturation
at 94 °C for 1 min, primer annealing at 55 °C for 1 min,
and chain elongation with 2 U of Pfu DNA polymerase
(Thermoscientific) at 72 °C for 40 s. PCR amplification
was carried out in a final volume of 50 μL of 10 mM
Tris–hydrochloride pH 8.3 containing 0.2 mM deoxynu-
cleotide triphosphates, 3 mM MgCl2, 50 mM KCl, 5 %
dimethyl sulfoxide (DMSO) and 0.25 μM of each pri-
mer [BST2 sense-EcoRV and BST2 –anti-NheI primers
(Table 1)]. The ~600 bp PCR amplicon product was
checked by sequencing and then subcloned in the expres-
sion vector pIres2neo (Clontech), cut with NheI/EcoRV,
to generate pCMV-boBST-2-IRES-neo.
To generate pCMV-IE1-IRES-neo, BoHV-4IE1 ORF
cDNA was amplified by PCR from reverse transcribed
total RNA of BoHV-4 infected BEK cells, using the
Ready to Go system (Amersham), according to the man-
ufacturer’s instructions. The PCR was performed using
IE1-NheI-sense and IE1-BamHI-antisense primers (see
Table 1) over 35 cycles, each cycle consisting of denatur-
ation at 94 °C for 1 min, primer annealing at 58 °C for
1 min, and chain elongation with 2 U of Pfu DNA poly-
merase (Thermoscientific) at 72 °C for 1 min. The amp-
lification was carried out in a final volume of 50 μL of
10 mM Tris–hydrochloride pH 8.3 containing 0.2 mM
deoxynucleotide triphosphates, 3 mM MgCl2, 50 mM
KCl, 5 % DMSO and 0.25 μM of each primer. The
900 bp IE1 ORF cDNA amplicon was then cut with
NheI/BamHI and inserted in an expression vector, pIr-
es2neo (Clontech) cut with the same enzymes.
To amplify Immediate Early 1 homology arm regions
one microgram of pBAC-BoHV-4 DNA sample was
amplified over 35 cycles, each cycle consisting of de-
naturation at 94 °C for 1 min, primer annealing at 56 °C
for 1 min, and chain elongation with 2 U of Pfu DNA
polymerase (Thermoscientific) at 72 °C for 2 min. PCR
amplification was carried out in a final volume of 50 μL of
10 mM Tris–hydrochloride pH 8.3 containing 0.2 mM
deoxynucleotide triphosphates, 3 mM MgCl2, 50 mM
KCl, 5 % DMSO and 0.25 μM of each primer. The primers
used to amplify BoHV-4IE1 left and right arms, were IE1-
left-sense and antisense (introducing a EcoRI site in the
sense primer and a KpnI site in the antisense) and IE1-
right-sense and antisense (inserting a PstI site in the sense
primer and a HindIII in the antisense primer) (see Table 1).
The so generated 938 and 992 bp amplicons (respectively
for the left and the right arms) were then checked in 1 %
agarose gel and visualized after ethidium bromide staining
in 1 × TAE buffer (40 mM Tris-acetate, 1 mM EDTA) and
used to subclone the IE1 left and right homology arm re-
gions in an expression vector. The specificity of the PCR
products were determined by sequencing.
The 938 and 992 bp BoHV-4IE1 left and right arm
amplicons were firstly inserted in pJET1.2, a commercial
vector from Thermoscientific, designed to directly sub-
clone blunt-ended PCR amplicons (as those generated by
Pfu polymerase amplification), using the CloneJet PCR
Cloning Kit (Thermoscientific), generating pJET/IE1left
and pJET/IE1 right.
pTZ-KanaGalK was generated by sub-cloning the
2232 bp galactokinase prokaryotic expression cassette
(GalK), along with the kanamycin resistant expression cas-
sette (Kana), into the pTZ57R/T shuttle vector, cut with
KpnI/PstI [30]. The targeting vector, pIE1L-KanaGalK-
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IE1R, was generated firstly by the insertion of the 930 bp
left IE1 arms, excised from pJET/IE1left, cut with EcoRI/
KpnI, in pTZ-KanaGalK, cut with the same enzymes; in
this intermediate construct, cut with PstI/HindIII, was
consequently subcloned the 983 bp right IE1 arm, ob-
tained from pJET/IE1right, cut with the same enzymes.
Stable cell lines generation
BEK cells from a sub-confluent 75 cm2 flask were electro-
porated (Equibio apparatus; 270 V, 1500 μF) with 10 μg of
pCMV-IE1-IRES-neo DNA in Dulbecco’s Modified Eagle
Medium with high glucose (DMEM high) without FBS.
Electroporated cells were transferred to new 75 cm2 flasks
and fed with complete medium (EMEM containing 10 %
FBS, 100 IU/mL of penicillin, 100 mg/mL streptomycin,
2.5 mg/mL amphotericin B, and 2 mM L-glutamine).
Twenty-four hours after electroporation, stably transfec-
ted cells were selected with 700 μg/mL of G418 (Sigma)
until visible colonies appeared on the surface of the flask.
Some selected clones were independently growth for 20
passages in the presence of G418. Thus, BEK stably
expressing IE1 cDNA, BEK/IE1, were obtained.
BEK cells from a sub-confluent 75 cm2 flask were also
transfected through electroporation (Equibio apparatus;
270 V, 1500 μF) with 10 μg of pCMV-boBST-2-IRES-neo
DNA in DMEM high in the absence of FBS. Electro-
porated cells were transferred to new 75 cm2 flasks
containing complete medium. Twenty-four hours after
electroporation, stably transfected cells were selected
with 700 μg/mL of G418 (Sigma) until visible colonies
appeared on the surface of the flask. The selective pres-
sure of G418 was maintained during the passages and
BEK stably expressing the flagged bovine tetherin cDNA,
BEK-boBST-2, were generated.
BAC recombineering and selection
Recombineering was performed as previously described
[31] with some modifications. Five hundred microliters
of a 32 °C overnight culture of SW102 containing BAC-
BoHV-4 were diluted in 25 mL Luria–Bertani (LB)
medium with or without chloramphenicol (SIGMA) se-
lection (12.5 μg/mL) in a 50 mL baffled conical flask and
grown at 32 °C in a shaking water bath to an OD600 of
0.6. Then, 12 mL were transferred to another baffled
50 mL conical flask and heat shocked at 42 °C for
exactly 15 min in a shaking water bath. The remaining
culture was left at 32 °C as the un-induced control. After
15 min the two samples, induced and un-induced, were
briefly cooled in ice/water bath slurry and then trans-
ferred to two 15 mL Falcon tubes and pelleted using
5000 r.p.m. (Eppendorf centrifuge) at 0 °C for 5 min.
The supernatant was poured off and the pellet was re-
suspended in 1 mL ice cold dH2O by gently swirling the
tubes in ice/water bath slurry. Subsequently, 9 mL ice-
cold dH2O were added and the samples pelleted again.
This step was repeated once more, the supernatant was
removed and the pellet (50 μL each) was kept on ice until
electroporated with the gel-purified IE1L-KanaGalK-IE1R
fragment obtained by linearizing pIE1L-KanaGalK-IE1R,
with HindIII (Thermoscientific). An aliquot of 150 ng of
the purified fragment was used for each electroporation in
a 0.1 cm cuvette at 25 mF, 2.5 kV and 201 V. After electro-
poration, a recovery of 1 h of the bacteria in 1 mL of LB
Broth (BD Biosciences) (15 mL Falcon tube) was per-
formed in a 32 °C shaking water bath. After two washes in
sterile M9 salt (6 g/L Na2HPO4, 3 g/L KH2PO4, 1 g/L
NH4Cl, 0.5 g/L NaCl) (SIGMA), serial dilutions of the
bacteria were plated on M63 minimal medium plates
containing 15 g/L agar (Invitrogen), 0.2 % D-galactose
(SIGMA), 1 mg/L D-biotin (SIGMA), 45 mg/L L-leucine
(SIGMA) and 12.5 mg/mL chloramphenicol (SIGMA).
Plates were incubated 3 days at 32 °C. Several selected
colonies were picked up, streaked on McConkey agar indi-
cator plates (DIFCO, BD Biosciences) containing 1 % D-
galactose and 50 μg/mL of kanamycin and incubated at
32 °C for 3 days until red colonies appeared. Red colonies
were grown in duplicate for 5–8 h in 1 mL of LB contain-
ing 50 mg/mL of kanamycin (SIGMA) or LB containing
12.5 mg/mL of chloramphenicol. Only those colonies
growing both on chloramphenicol and on kanamycin were
kept and grown overnight in 5 mL of LB containing
12.5 mg/mL of chloramphenicol. BAC DNA was purified
and analyzed through restriction enzyme digestion for
IE1L-KanaGalK-IE1R fragment targeted integration.
Original detailed protocols for recombineering can
also be found at the recombineering website (http://
recombineering.ncifcrf.gov).
Restriction enzyme analysis and non-isotopic Southern
hybridization
Fifteen microliters of BAC DNA prepared from bacteria
containing pBAC-BoHV-4 were restriction enzyme diges-
ted with PstI, separated by electrophoresis overnight in a
1 % agarose gel, stained with ethidium bromide, capillary
transferred to a positively charged nylon membrane
(Roche), and cross-linked by UV irradiation by standard
procedures. The membrane was pre-hybridized in 50 mL
of hybridization solution (7 % SDS, 0.5 M phosphate,
pH 7.2) for 1 h at 65 °C in a rotating hybridization oven
(Techna instruments). Probe preparation and digoxigenin
non-isotopic labelling was performed by PCR. Southern
Blotting probe was designed spanning Kana region using
the primer pair SmaI-AseI-Kana sense and SmaI-MluI-
Kana anti (see Table 1). PCR amplification was carried
out in a final volume of 50 μL of 10 mM Tris–HCl,
pH 8.3, containing 0.2 mM deoxynucleotide triphos-
phates, 0.02 mM alkaline labile digoxigenin-dUTP (deox-
yuridine triphosphate) (Roche), 3 mM MgCl2, 50 mM
Franceschi et al. BMC Veterinary Research  (2015) 11:224 Page 8 of 11
KCl, and 0.25 μM of each primer over 35 cycles, each
cycle consisting of denaturation at 94 °C for 1 min, primer
annealing at 56 °C for 1 min, and chain elongation with 1
U of Taq polymerase (Thermoscientific) at 72 °C for
1 min. Five microliters of the probe were added to 500 μL
of dH2O into a screw-cap tube, denatured in boiling water
for 5 min, and cooled down on ice for another 2 min. De-
natured probe was added to 50 mL of pre-heated 65 °C
hybridization solution [7 % SDS, 0.5 M phosphate, pH 7.2
and 1 mM ethylenediaminetetraacetic acid (EDTA)] to the
pre-hybridized membrane and hybridized overnight at
65 °C in a rotating hybridization oven (Techna Ins-
truments). Following hybridization, the membrane was
washed twice for 30 min with 100 mL of washing solution
I (0.5× SSC [1× SSC is 0.15 M NaCl plus 0.015 M sodium
citrate] and 0.1 % SDS) and twice for 30 min with 100 mL
of washing solution II (40 mM phosphate, pH 7.2, 0.05 %
SDS) at 65 °C. On a freshly washed dish, the membrane
was incubated for 30 min at room temperature in 100 mL
of blocking solution (100 mM maleic acid, pH 7.5,
150 mM NaCl, 1 % blocking reagent [Roche]). Anti-
digoxigenin Fab fragment (150 U/200 μL [Roche]), diluted
1:15.000 in 50 mL of blocking solution, was applied to the
membrane for 30 min under gentle shaking at room
temperature and washed twice for 15 min with 100 mL of
washing solution (100 mM maleic acid, pH 7.5, 150 mM
NaCl, 0.3 % Tween 20). Detection was performed follow-
ing equilibration of the membrane in detection buffer
(100 mM Tris–HCl, pH 9.5, 1 mM EDTA) for 2 min at
room temperature. Chemiluminescent substrate (CSPD,
Roche) was added by scattering the drops over the
surface of the membrane. Signal detection was obtained,
exposing the membrane to X-ray film. The exposure time
was adjusted with the intensity of the signal.
Cell culture electroporation and recombinant virus
reconstitution
Plasmid BAC DNAs (5 μg) in 600 μL DMEM without
serum were electroporated (Equibio apparatus, 270 V,
960 μF, 4-mm gap cuvettes) into BEK or BEKcre cells
from a confluent 25 cm2 flask. Electroporated cells were
then returned to the flask, fed the next day, and split 1:2
when they reached confluence at 2 days post electropor-
ation. Cells were left to grow until Cytopathic Effect
(CPE) appeared. Recombinant viruses were propagated
by infecting confluent monolayers of BEK and MDBK
cells at a multiplicity of infection (m.o.i.) of 0.5 50 % tis-
sue culture infectious doses (TCID50) per cell and main-
taining them in MEM with 10 % fetal bovine serum
(FBS) for 2 hs. The medium was removed and replaced
by fresh MEM containing 10 % FBS. When approxi-
mately 90 % of the cell monolayer exhibited CPE (~72 h
post infection), the virus was prepared by freezing and
thawing cells three times and pelleting virions through
30 % sucrose, as described previously [16]. Virus pellets
were resuspended in cold MEM without FBS. TCID50 were
determined on MDBK or BEK cells by limiting dilution.
Viruses and viral replication
Bovine herpesvirus-4 (BoHV-4), BoHV-4ΔTK [15] and
BoHV-4ΔIE1, were propagated by infecting confluent
monolayers of VERO, BEK, BEK-IE1 and BEK-boBST2
cells at a multiplicity of infection (m.o.i.) of 0.5 50 % tissue
culture infectious doses (TCID50) per cell and maintained
in MEM with 10 % FBS for 2 hs. The medium was then
removed and replaced by fresh MEM containing 10 %
FBS. When approximately 90 % of the cell monolayer
exhibited cytopathic effect (CPE) (approximately 72 hs
post-infection), the virus was prepared by freezing and
thawing cells three times and pelleting the virions through
30 % sucrose, as described above. Virus pellets were resus-
pended in cold MEM without FBS. TCID50 were deter-
mined in BEK or MDBK cells by limiting dilution. Viruses
growth kinetics were assessed infecting BEK, BEK-IE1 and
BEK-boBST2 cells with 0.1 m.o.i. of virus, cells were mon-
itored periodically for 72 hs at the microscope to verify
the CPE appearance and small aliquots of medium were
recovered at 24, 48 and 72 hs and titrated in BEK cells.
Viral titer differences between each time point are the
averages of triplicate measurements ± standard errors of
the means and were analyzed by analysis of variance
(ANOVA).
Viral plaque assay
VERO cell monolayers were infected with BoHV-4 and
BoHV-4ΔIE1 with serial 10-fold dilutions of the viruses
and incubated at 37 °C for 2 hs. Infected cells were then
overlaid with fresh 2X EMEM (4 mM L-glutamine,
200 IU/mL penicillin, 200 mg/mL streptomycin, 5 mg/mL
amphotericin B) supplemented with 12 % FBS and 0,6 %
of carboxymethyl-cellulose. Cells were incubated at 37 °C
with a 5 % CO2 atmosphere for 5 ds until the plaques
were visible. The medium was discarded and, after a wash
with sterile phosphate buffer saline (PBS), the cellular
monostrates were fixed in 4 % Paraformaldehyde for
15 min at room temperature, and stained with 0,5 %
crystal violet in absolute ethanol for 5–10 min at
room temperature. Cells were washed with tap water
and left to dry at room temperature. The diameter of
the plaques was measured through a software for image
analysis (AxioVision Rel. 4.6. digital image processing soft-
ware; Carl Zeiss).
Western immunoblotting
Cell extracts were obtained from BEK-boBST2 scraped
from 25 cm2 confluent flasks at several different passage
levels (from 2nd to 10th) by adding 100 μL of cell ex-
traction buffer (50 mM Tris–HCl, 150 mM NaCl, and
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1 % NP-40; pH 8) to cell pellets. Cell extracts containing
50 μg of total protein were electrophoresed through so-
dium dodecyl sulfate-10 % polyacrylamide gels and
transferred to nylon membranes by electroblotting.
Membranes were incubated with mouse anti-FLAG M2
monoclonal antibody (1:1000 dilution; F1804; SIGMA),
which was detected with horseradish peroxidase-labelled
goat anti rabbit immunoglobulin G1 (IgG1) antibody
(1:15.000; A0545; Sigma), and visualized by enhanced
chemiluminescence (ECL Kit; Pierce).
Statistics
Data were analyzed using one way analysis of variance
(ANOVA) followed by Dunnet’s post hoc test for group
comparisons. Results are reported as mean ± SD and sig-
nificance was attributed when P,0.05 (*) or P,0.01 (**).
Additional file
Additional file 1: Alignment between KSHV K5 and BoHV-4IE1
protein sequence. The sequence of KSHV K5 protein was aligned with
BoHV-4 Immediate early 1 gene product to highlight the percentage
of sequence identities and positive matches through the alignment
software BLAST-2 (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=
blastp&PAGE_TYPE=BlastSearch&BLAST_SPEC=blast2seq&LINK_LOC=
blasttab). (TIFF 5192 kb)
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